These trials evaluated SABA alone, ICS with formoterol, and ICS with SABA (combined or separate inhalers). Patients had a mean age of 41 years, and 41% were male. Median treatment duration of the ...

but currently there are no ICS/SABA preparations available. That means carrying two different inhalers, with potentially different designs. Again, this hurts the compliance argument inherent to ...

The patient lists were generated using searches to identify asthma patients without a diagnosis of COPD, who have SABA inhalers, but no ICS inhalers, on their repeat medication list. Data was gathered ...

The analysis also shows that heavy users who went through three or more SABA inhalers in a year were 32 ... therapy with inhaled corticosteroids (ICS), used to dampen down the inflammation seen ...

Airsupra (formerly PTO27) has been approved in the US since the start of 2023 for as-needed use to reduce the risk of asthma exacerbations, the first drug to combine a SABA and ICS in one inhaler ...